(firstQuint)Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD.

 For the treatment of pediatric patients who have failed to respond to steroid treatment for acute graft-versus-host disease (GVHD).

 Failing steroid treatment for acute GVHD is defined as any Grade B-D (IBMTR grading) of acute GVHD that is not improving after at least 3 days of methylprednisolone ( 1 mg/kg/day) or equivalent.

 Patients will be treated with Prochymal twice per week at a dose of 2 x 10^6 hMSC/kg (actual body weight) for each of 4 consecutive weeks.

 Infusions will be administered at least 3 days apart.

.

 Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD@highlight

This protocol allows for the treatment of pediatric patients, male and female, between the ages of 2 months and 17 years.

 Patients must have failed steroid treatment for Grade B-D acute GVHD.

